Financhill
Back

Northwest Biotherapeutics, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
14

NWBO
Northwest Biotherapeutics, Inc.

Last Price:
$0.20
Seasonality Move:
2.63%

7 Day Trial

ALL ACCESS PASS

$ 7
  • The current trend is relatively stagnant and NWBO is experiencing selling pressure, which indicates risk of future bearish movement.

Northwest Biotherapeutics, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 0.21 Sell
20-day SMA: 0.21 Sell
50-day SMA: 0.24 Sell
200-day SMA: 0.25 Sell
8-day EMA: 0.19 Buy
20-day EMA: 0.14 Buy
50-day EMA: 0.07 Buy
200-day EMA: 0.02 Buy

Northwest Biotherapeutics, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.06 Buy
Relative Strength Index (14 RSI): 39.2 Sell
Chaikin Money Flow: -102069 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.21 - 0.23) Sell
Bollinger Bands (100): (0.22 - 0.28) Sell

Northwest Biotherapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Northwest Biotherapeutics, Inc. Stock

Is Northwest Biotherapeutics, Inc. Stock a Buy?

NWBO Technical Analysis vs Fundamental Analysis

Sell
14
Northwest Biotherapeutics, Inc. (NWBO) is a Sell

Is Northwest Biotherapeutics, Inc. a Buy or a Sell?

Northwest Biotherapeutics, Inc. Stock Info

Market Cap:
307.8M
Price in USD:
0.20
Share Volume:
1.3M

Northwest Biotherapeutics, Inc. 52-Week Range

52-Week High:
0.48
52-Week Low:
0.17
Sell
14
Northwest Biotherapeutics, Inc. (NWBO) is a Sell

Northwest Biotherapeutics, Inc. Share Price Forecast

Is Northwest Biotherapeutics, Inc. Stock a Buy?

Fundamental Analysis of Northwest Biotherapeutics, Inc.

Is Northwest Biotherapeutics, Inc. a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.02 per share.

Technical Analysis of Northwest Biotherapeutics, Inc.

Should I short Northwest Biotherapeutics, Inc. stock?

* Northwest Biotherapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.